Skip to content

Advertisement

Open Peer Review Reports for: Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
26 Feb 2007 Submitted Original manuscript
6 Mar 2007 Author responded Author comments - Gustavo Viani
Resubmission - Version 2
6 Mar 2007 Submitted Manuscript version 2
23 Mar 2007 Reviewed Reviewer Report - David Miles
16 Apr 2007 Reviewed Reviewer Report - Andrew Roddam
27 May 2007 Author responded Author comments - Gustavo Viani
Resubmission - Version 3
27 May 2007 Submitted Manuscript version 3
7 Jun 2007 Reviewed Reviewer Report - Andrew Roddam
28 Jul 2007 Author responded Author comments - Gustavo Viani
Resubmission - Version 4
28 Jul 2007 Submitted Manuscript version 4
31 Jul 2007 Author responded Author comments - Gustavo Viani
Resubmission - Version 5
31 Jul 2007 Submitted Manuscript version 5
3 Aug 2007 Author responded Author comments - Gustavo Viani
Resubmission - Version 6
3 Aug 2007 Submitted Manuscript version 6
Publishing
8 Aug 2007 Editorially accepted
8 Aug 2007 Article published 10.1186/1471-2407-7-153

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement